LightSpeed VCT XT saves resources

The Cardiocentro Ticino in Lugano, Switzerland ' a tertiary care centre specialising in treating patients with coronary artery disease ' carries out around 300 major operations and 2,000 invasive coronary angiographies annually. Six months ago, the hospital acquired state-of-the art equipment, including GE's LightSpeed VCT XT.

Dr Francesco Faletra
Dr Francesco Faletra

‘Acquisition of the GE VCT was done in conjunction with the purchase of a major package, containing updated echocardiographic equipment and solutions for the electrophysiological and cardiac catheterisation laboratories,’ said Dr Francesco Faletra, Director of the centre’s cardiac imaging unit. ‘Since the installation, our team has performed 2,100 examinations using the new system. The LightSpeed VCT is an ideal solution for screening patients with atypical chest pain and low to intermediate risk of coronary artery disease because this technique has a high negative predictive value. We now examine patients by carrying out a cardiac VCT scan instead of an invasive coronary angiography, which saves valuable resources: the invasive catheterisation laboratories can now be used primarily for angioplasty.’
Due to technologies like SnapShot Pulse, the dose for a CT scan with LightSpeed VCT can be reduced by up to 70%, ranging from 1.5 to 4mSV. ‘That enables us to study even asymptomatic patients, provided they show a high-risk profile, which is a real benefit. Moreover we can repeat an examination after six months or a year to track coronary plaque after pharmacological treatments, or a change in lifestyle,’ he pointed out. 
Next to the quite user friendly software the VCT enables heart scans in 10 seconds, thus optimising the workflow in the radiology department. ‘With the new system we achieved great results - we expect even more in the future,’ Dr Faletra predicted.

30.10.2007

Read all latest stories

Related articles

Photo

Enhancement in minimally-invasive treatment of heart rhythm disorders

The Catharina Hospital (Eindhoven, the Netherlands) and Royal Philips (NYSE: PHG, AEX: PHIA) today announced the results of a clinical study involving the treatment of 136 patients with complex heart…

Cardiac conundrum

France – Re-opening clogged arteries with metal stents has proved a life-saver for a majority of patients with coronary disease. Yet the high rates of complications and mortality for patients with…

Photo

Leading the field in PAD treatment

Around 18,472 angioplasty procedures and 4,752 stent procedures were completed in Germany in 2008. By comparison, only 7,710 angioplasty procedures and 438 stent procedures were completed in the same…

Related products

Alsachim – Dosinaco anticoagulant reagent kit (RUO)

Clinical Chemistry

Alsachim – Dosinaco anticoagulant reagent kit (RUO)

Alsachim, a Shimadzu Group Company
Beckman Coulter – DxA 5000

Automation

Beckman Coulter – DxA 5000

Beckman Coulter Diagnostics
Beckman Coulter – DxONE Command Central Workstation

LIS, Middleware, POCT

Beckman Coulter – DxONE Command Central Workstation

Beckman Coulter Diagnostics
Bracco – Nexo [Dose]

Accessories / Complementary Systems

Bracco – Nexo [Dose]

Bracco Imaging SpA
Canon Electron Tubes & Devices – LM-Angio Tube

Accessories/ Complementary Systems

Canon Electron Tubes & Devices – LM-Angio Tube

Canon Electron Tubes & Devices Co., Ltd
CliniSys | MIPS – CyberLab

LIS, Middleware, POCT

CliniSys | MIPS – CyberLab

CliniSys | MIPS Deutschland GmbH
Subscribe to Newsletter